Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.4069
-0.0467 (-10.30%)
Nov 16, 2026, 4:00 PM EST - Market closed

Kairos Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11520---
Market Cap Growth
-92.19%-24.29%----
Enterprise Value
-2916---
Last Close Price
0.414.9710.64---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.392.334.09---
P/TBV Ratio
0.362.354.29---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.31-0.50-0.34
Net Debt / Equity Ratio
-0.81-0.71-0.27-0.26-0.13-0.28
Net Debt / EBITDA Ratio
0.490.830.58-0.35-0.36-0.17
Quick Ratio
6.3122.571.280.040.270.04
Current Ratio
6.7727.074.200.040.270.04
Return on Equity (ROE)
-110.77%-97.99%-192.96%---
Return on Assets (ROA)
-65.65%-56.59%-43.50%-107.07%-39.41%-307.71%
Return on Capital Employed (ROCE)
-168.50%-87.90%-49.10%119.00%95.60%166.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-506.91%-36.85%-13.33%---
Buyback Yield / Dilution
-31.01%-62.27%-9.38%-1.42%-11.86%3.12%
SEC Filings: 10-K · 10-Q